Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Outros Autores: | , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UFBA |
Texto Completo: | http://www.repositorio.ufba.br/ri/handle/ri/5767 |
Resumo: | Acesso restrito: Texto completo. p. 463-466 |
id |
UFBA-2_19f2120a01fd9ad4250acc44cde43089 |
---|---|
oai_identifier_str |
oai:repositorio.ufba.br:ri/5767 |
network_acronym_str |
UFBA-2 |
network_name_str |
Repositório Institucional da UFBA |
repository_id_str |
1932 |
spelling |
Magalhães, ElzaMenezes, CarlaCardeal, MauricioMelo, Ailton de SouzaMagalhães, ElzaMenezes, CarlaCardeal, MauricioMelo, Ailton de Souza2012-05-03T19:21:48Z20100303-8467http://www.repositorio.ufba.br/ri/handle/ri/5767v. 112, n. 6Acesso restrito: Texto completo. p. 463-466Objective: To compare the effects of botulinum toxin type A with those of amitriptyline on the treatment of chronic daily migraines. Methods: Chronic migraine sufferers were randomized into two groups and treated with 25 or 50 mg/day of amitriptyline or 250U of botulinum toxin type A. A reduction of at least 50% in the number of pain episodes, in the intensity of pain, and in the number of drug doses for pain and reports of improvement by the patient or by the examiner were the main endpoints. Results: Seventy-two subjects were enrolled in the study. A reduction of at least 50% in the number of days of pain was recorded in 67.8% of the patients in the BTX-A group and 72% (n = 23) of the patients in the AM group (p = 0.78; RR = 0.94; CI = 0.11–8). The reduction in the intensity of pain, as assessed using the visual analogical scale, was 50% in the BXT-A group and 55.6% in the AM group (p = 0.79; RR = 1.11; CI = 0.32–3.8). The reduction in the number of pain drug doses was 77% for the toxin group and 71% for the amitriptyline group (p = 0.76; RR = 0.92; CI = 0.45–1.88). Conclusions: Botulinum toxin type A was as effective as amitriptyline for the prophylactic treatment of chronic daily migraines.Submitted by JURANDI DE SOUZA SILVA (jssufba@hotmail.com) on 2012-05-03T19:21:48Z No. of bitstreams: 1 __ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf: 96186 bytes, checksum: d7e81783ccc1abefedcc2130a48ec01f (MD5)Made available in DSpace on 2012-05-03T19:21:48Z (GMT). No. of bitstreams: 1 __ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf: 96186 bytes, checksum: d7e81783ccc1abefedcc2130a48ec01f (MD5) Previous issue date: 2010DOI: 10.1016/j.clineuro.2010.02.004reponame:Repositório Institucional da UFBAinstname:Universidade Federal da Bahia (UFBA)instacron:UFBAChronic migraineAmitriptylineBotulinum toxinBotulinum toxin type A versus amitriptyline for the treatment of chronic daily migraineClinical Neurology and Neurosurgeryinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10000-01-01enginfo:eu-repo/semantics/openAccessORIGINAL__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdfapplication/pdf96186https://repositorio.ufba.br/bitstream/ri/5767/1/__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdfd7e81783ccc1abefedcc2130a48ec01fMD51LICENSElicense.txtlicense.txttext/plain1762https://repositorio.ufba.br/bitstream/ri/5767/2/license.txt1b89a9a0548218172d7c829f87a0eab9MD52TEXT__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf.txt__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf.txtExtracted texttext/plain19009https://repositorio.ufba.br/bitstream/ri/5767/3/__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf.txt152139dc1a4ca8b672643bed94a83466MD53ri/57672022-07-05 14:03:20.925oai:repositorio.ufba.br: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Repositório InstitucionalPUBhttp://192.188.11.11:8080/oai/requestopendoar:19322022-07-05T17:03:20Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA)false |
dc.title.pt_BR.fl_str_mv |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
dc.title.alternative.pt_BR.fl_str_mv |
Clinical Neurology and Neurosurgery |
title |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
spellingShingle |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine Magalhães, Elza Chronic migraine Amitriptyline Botulinum toxin |
title_short |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
title_full |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
title_fullStr |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
title_full_unstemmed |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
title_sort |
Botulinum toxin type A versus amitriptyline for the treatment of chronic daily migraine |
author |
Magalhães, Elza |
author_facet |
Magalhães, Elza Menezes, Carla Cardeal, Mauricio Melo, Ailton de Souza |
author_role |
author |
author2 |
Menezes, Carla Cardeal, Mauricio Melo, Ailton de Souza |
author2_role |
author author author |
dc.contributor.author.fl_str_mv |
Magalhães, Elza Menezes, Carla Cardeal, Mauricio Melo, Ailton de Souza Magalhães, Elza Menezes, Carla Cardeal, Mauricio Melo, Ailton de Souza |
dc.subject.por.fl_str_mv |
Chronic migraine Amitriptyline Botulinum toxin |
topic |
Chronic migraine Amitriptyline Botulinum toxin |
description |
Acesso restrito: Texto completo. p. 463-466 |
publishDate |
2010 |
dc.date.issued.fl_str_mv |
2010 |
dc.date.accessioned.fl_str_mv |
2012-05-03T19:21:48Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://www.repositorio.ufba.br/ri/handle/ri/5767 |
dc.identifier.issn.none.fl_str_mv |
0303-8467 |
dc.identifier.number.pt_BR.fl_str_mv |
v. 112, n. 6 |
identifier_str_mv |
0303-8467 v. 112, n. 6 |
url |
http://www.repositorio.ufba.br/ri/handle/ri/5767 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.pt_BR.fl_str_mv |
DOI: 10.1016/j.clineuro.2010.02.004 |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFBA instname:Universidade Federal da Bahia (UFBA) instacron:UFBA |
instname_str |
Universidade Federal da Bahia (UFBA) |
instacron_str |
UFBA |
institution |
UFBA |
reponame_str |
Repositório Institucional da UFBA |
collection |
Repositório Institucional da UFBA |
bitstream.url.fl_str_mv |
https://repositorio.ufba.br/bitstream/ri/5767/1/__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf https://repositorio.ufba.br/bitstream/ri/5767/2/license.txt https://repositorio.ufba.br/bitstream/ri/5767/3/__ac.els-cdn.com_S030384...f27d3c08fc3ed10c3efbf15a99171.pdf.txt |
bitstream.checksum.fl_str_mv |
d7e81783ccc1abefedcc2130a48ec01f 1b89a9a0548218172d7c829f87a0eab9 152139dc1a4ca8b672643bed94a83466 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFBA - Universidade Federal da Bahia (UFBA) |
repository.mail.fl_str_mv |
|
_version_ |
1808459397544804352 |